# A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers

> **NCT02953132** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 116 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MT-4129
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02953132
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953132, "A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02953132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*